# Oculogica, Inc.

- Location (FDA's records): New York, NY
- FDA decisions: 6 (2018–2026): 5 510(k) clearances and 1 De Novo grant
- Product codes: QEA (6)
- Predicates its devices cite: 6 (5 its own); citations of its devices by later devices: 6 (5 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Syncthink, Inc.: 1 (https://510kreport.com/company/syncthink)

## Firms that cite its devices most
- Syncthink, Inc.: 1 (https://510kreport.com/company/syncthink)

## Its most-cited devices
- DEN170091: EyeBOX (2018), cited by 2
- K201841: EyeBOX (2020), cited by 1
- K242116: EyeBOX EBX-4.1 (2025), cited by 1
- K191183: EyeBOX (2019), cited by 1
- K212310: EyeBOX (Model EBX-4) (2021), cited by 1

## Recent decisions
- K254086: EyeBOX SNAP (Jun 5, 2026)
- K242116: EyeBOX EBX-4.1 (Apr 4, 2025)
- K212310: EyeBOX (Model EBX-4) (Dec 22, 2021)
- K201841: EyeBOX (Sep 6, 2020)
- K191183: EyeBOX (Jul 31, 2019)
- DEN170091: EyeBOX (Dec 28, 2018)

Source page: https://510kreport.com/company/oculogica